Hollsteen
← Marvell

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2019: $7.3B · 10-K 0001835632-22-000016 filed Mar 10, 2022Equity incl. NCI · FY2020: $8.7B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2021: $8.4B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2022: $15.7B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2023: $15.6B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2024: $14.8B · 10-K 0001835632-24-000009 filed Mar 13, 2024Equity incl. NCI · FY2025: $13.4B · 10-K 0001835632-25-000057 filed Mar 12, 2025Equity incl. NCI · FY2026: $14.3B · 10-K 0001835632-26-000011 filed Mar 11, 2026missing14.37.315.7FY2016FY2026FY2021
$BEquity incl. NCI · FY2021: $8.4B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2022: $15.7B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2023: $15.6B · 10-K 0001835632-23-000013 filed Mar 9, 2023Equity incl. NCI · FY2024: $14.8B · 10-K 0001835632-24-000009 filed Mar 13, 2024Equity incl. NCI · FY2025: $13.4B · 10-K 0001835632-25-000057 filed Mar 12, 2025Equity incl. NCI · FY2026: $14.3B · 10-K 0001835632-26-000011 filed Mar 11, 202614.38.415.7FY2021FY2026FY2024
FY2026
14.3$B
All values (8)
PeriodValue ($B)Status
FY202614.3reported
FY202513.4reported
FY202414.8reported
FY202315.6reported
FY202215.7reported
FY20218.4reported
FY20208.7reported
FY20197.3reported
FY2016 – FY2018–missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Marvell

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$14.3B
Period
FY2026, ended Jan 31, 2026 · as of Jan 31, 2026 (balance as of date, not a sum)
Source
10-K, filed Mar 11, 2026 · 0001835632-26-000011
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$14.3BMar 11, 202610-K 0001835632-26-000011reported · confidence 1. · current